ADARx Pharmaceuticals, Inc. ADRX
12.84 USD -0.45 (-3.39%)
Nov 6, 2026, 1:40 PM EST
12.74 Day range 13.68
12.74 52-week range 23.21
- YTD
- -33.64%
- 1 year
- -33.64%
Ownership
Held by insiders 41.78%
Held by institutions 49.17%
Float held by institutions 84.45%
Institutions 22
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Laurion Capital Management, LP | 0.02% | 20,000 | 265.80K | Sep 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| SmallCap World Fund Inc | 3.18% | 3,246,801 | 43.15M | Sep 29, 2026 |
| Fidelity Contrafund | 0.46% | 467,700 | 6.22M | Sep 29, 2026 |
| AB CAP FUND, INC.-AB Small Cap Growth Portfolio | 0.42% | 430,729 | 5.72M | Sep 29, 2026 |
| AB DISCOVERY GROWTH FUND, INC. | 0.42% | 427,316 | 5.68M | Sep 29, 2026 |
| Fidelity Select Portfolios-Select Health Care Portfolio | 0.39% | 400,000 | 5.32M | Sep 29, 2026 |
| Fidelity Securities Fund-Fidelity Blue Chip Growth Fund | 0.32% | 328,200 | 4.36M | Sep 29, 2026 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CHIMOVITS EREZ | Director | Purchase | Sep 27, 2026 | 0 |
| GEORGE SIMEON J. | Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Sep 27, 2026 | 0 |
| GORDON CARL L | Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Sep 27, 2026 | 0 |
| LAV BIOSCIENCES FUND V LP | Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Sep 27, 2026 | 0 |
| ORBIMED ADVISORS, L.L.C. | Beneficial Owner of more than 10% of a Class of Security | Purchase | Sep 27, 2026 | 0 |
| SR ONE CAPITAL MANAGEMENT, LLC | Beneficial Owner of more than 10% of a Class of Security | Purchase | Sep 27, 2026 | 0 |